Anemia Drug, Eprex, Recalled by Johnson & Johnson

by Savitha C Muppala on  September 24, 2011 at 10:41 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Johnson & Johnson has announced the recall of close to 200,000 syringes of Eprex, a drug used to treat anemia.

The recall has been announced in 17 countries which includes Europe and Canada, No recall has been announced in the U.S. 

 Anemia Drug, Eprex, Recalled by Johnson & Johnson
Anemia Drug, Eprex, Recalled by Johnson & Johnson

The reason for the recall is not due to any adverse side effects but due to certain irregularities in the potency of dosages, which the company seeks to rectify. 

  

 



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Anemia Rheumatic Fever Thalassemia Anemia in Pregnancy Iron & Folate Deficiency Anemia In Pregnancy Diet for Anemia in Pregnancy The Basics of Baby Food Anemia in Children with Chronic Kidney Disease Iron Deficiency Anemia Top Iron-Rich Foods 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive